GLIBENCLAMIDE

Glibenclamide is a sulfonylurea stimulating insulin release to treat type 2 diabetes. Side effects include hypoglycemia, weight gain, and GI upset. Only GMP materials will be supplied, logistics all according to GDP.

SKU: 86c7228dd0eb Category: Tag:

Product Description


Mechanism of Action

Glibenclamide (glyburide) is a sulfonylurea that closes ATP-sensitive potassium (K⁺ATP) channels on pancreatic beta cells, triggering depolarization, calcium influx and insulin release.

Benefits and Advantages

Used in K⁺ATP-channel studies, insulin-secretion assays, metabolic disorder research and pancreatic beta-cell modelling.

Side Effects and Risks

Hypoglycemia, weight gain and rare hematologic reactions.

Only GMP materials will be supplied, logistics all according to GDP.

Datasheet


Molecular Formula

C23H28ClN3O5S

Molecular Weight

494.0 g/mol

CAS Number

10238-21-8

Storage Condition

Store in a cool, dry place. Keep container tightly closed. Protect from moisture and light.

Solubility

2.06e-03 g/L

Purity

Purity information is available upon request (COA).

Synonym

glyburide; Glibenclamide; 10238-21-8; Glynase; Euglucon

IUPAC/Chemical Name

5-chloro-N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-2-methoxybenzamide

InChl Key

ZNNLBTZKUZBEKO-UHFFFAOYSA-N

InChl Code

InChI=1S/C23H28ClN3O5S/c1-32-21-12-9-17(24)15-20(21)22(28)25-14-13-16-7-10-19(11-8-16)33(30,31)27-23(29)26-18-5-3-2-4-6-18/h7-12,15,18H,2-6,13-14H2,1H3,(H,25,28)(H2,26,27,29)

References

https://pubchem.ncbi.nlm.nih.gov/compound/3488;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download